Cephalexin (Keftab) vs Alternative Antibiotics: Comparison Guide

Cephalexin (Keftab) vs Alternative Antibiotics: Comparison Guide
Oct, 1 2025

Cephalexin vs Alternative Antibiotics Comparison Tool

Select an Antibiotic to Compare

Comparison Results

Side Effect Summary

Cephalexin: Nausea, rash

Amoxicillin: Diarrhoea, rash

Doxycycline: Photosensitivity, GI upset

Clindamycin: GI upset, C. difficile

Cefuroxime: Diarrhoea, rash

Every year the NHS records over three million courses of Cephalexin a first‑generation cephalosporin sold under the brand name Keftab. It’s a go‑to for skin and soft‑tissue infections, but patients often wonder whether another pill might work better, cost less, or be safer in pregnancy. This guide breaks down the science, the side‑effects, and the price tags so you can see where Cephalexin stands next to its most common rivals.

Cephalexin is the keyword that’ll keep popping up, because it’s the centerpiece of this comparison.

Key Takeaways

  • Cephalexin is a first‑generation cephalosporin, ideal for uncomplicated skin infections.
  • Amoxicillin covers many of the same bugs but adds activity against some Gram‑negative bacteria.
  • Doxycycline offers a broad spectrum and works well for atypical respiratory bugs.
  • Clindamycin is useful for anaerobic infections and MRSA, but carries a higher risk of C.difficile.
  • Cefuroxime bridges the gap between first‑ and second‑generation cephalosporins, with a broader Gram‑negative reach.

What Is Cephalexin (Keftab)?

Cephalexin belongs to the cephalosporin class - a family of beta‑lactam antibiotics that interfere with bacterial cell‑wall synthesis. Its chemical formula is C₁₆H₁₈N₃O₄S, and it’s marketed in the UK primarily as the 250mg and 500mg oral tablets. The drug is absorbed quickly, reaching peak plasma concentrations within an hour, and is excreted unchanged by the kidneys.

Typical uses include:

  • Uncomplicated cellulitis
  • Impetigo
  • Simple urinary tract infections (UTIs) caused by susceptible E.coli
  • Bone and joint infections where the pathogen is known to be sensitive

Because it’s a beta‑lactam, Cephalexin works best against Gram‑positive cocci such as Staphylococcus aureus (non‑MRSA) and Streptococcus pyogenes.

Dosing, Side Effects, and Safety Profile

Standard adult dosing is 250mg every six hours or 500mg every 12hours for 7‑10days, depending on infection severity. For kids, the dose is weight‑based (25mg/kg/day divided three times).

Common side effects (seen in up to 10% of patients) include mild nausea, diarrhoea, and a transient rash. Rare but serious reactions involve Stevens‑Johnson syndrome and anaphylaxis, especially in patients with a penicillin allergy - cross‑reactivity is reported at about 5%.

Renal impairment requires dose adjustment, and the drug is generally considered safe in pregnancy (Category B in the UK) though doctors prefer erythromycin for certain infections.

Top Alternatives to Cephalexin

Top Alternatives to Cephalexin

Below are the most frequently prescribed oral antibiotics that can be swapped for Cephalexin, each with its own niche.

Amoxicillin a broad‑spectrum penicillin often used for respiratory and ear infections

Amoxicillin’s spectrum covers many Gram‑positive bacteria plus a larger share of Gram‑negative organisms like H.influenzae. It’s taken three times daily, usually 500mg, and is cheap on the NHS formulary.

Doxycycline a tetracycline antibiotic effective against atypical pathogens and some resistant strains

Doxycycline is a favorite for Lyme disease, chlamydia, and community‑acquired pneumonia caused by Mycoplasma. The usual adult dose is 100mg twice daily. It’s not recommended for pregnant women or children under eight because it can affect tooth development.

Clindamycin a lincosamide that excels against anaerobes and certain MRSA strains

Clindamycin is often reserved for deep skin infections where anaerobes are suspected. It’s dosed 150‑300mg four times daily. The biggest downside is a 15‑20% chance of causing Clostridioides difficile colitis.

Cefuroxime a second‑generation cephalosporin with better Gram‑negative coverage than Cephalexin

Cefuroxime bridges the gap between first‑ and later‑generation cephalosporins. It’s taken twice daily (250‑500mg) and handles infections like otitis media and sinusitis more reliably than Cephalexin.

Side‑by‑Side Comparison

Cephalexin vs Common Alternatives
Attribute Cephalexin (Keftab) Amoxicillin Doxycycline Clindamycin Cefuroxime
Drug class First‑gen cephalosporin Penicillin Tetracycline Lincosamide Second‑gen cephalosporin
Typical infections Skin, uncomplicated UTI Respiratory, ear, sinus Lyme, atypical pneumonia MRSA, anaerobic, deep skin Sinus, otitis, pneumonia
Dosage frequency Q6‑12h Q8‑12h BID Q6‑8h BID
Pregnancy safety (UK) Category B Category B Contraindicated Category C Category B
Common side effects Nausea, rash Diarrhoea, rash Photosensitivity, GI upset GI upset, C.difficile Diarrhoea, rash
Cost (NHS list price) ÂŁ0.25 per tablet ÂŁ0.20 per tablet ÂŁ0.35 per tablet ÂŁ0.45 per tablet ÂŁ0.30 per tablet

Which One Fits Your Situation?

Skin infections without MRSA suspicion? Cephalexin remains the cheapest, well‑tolerated first line.

Lower respiratory tract infections? Amoxicillin or Cefuroxime usually beat Cephalexin because they hit more Gram‑negative bacteria.

Travel‑related fevers, atypical pneumonia, or chlamydia? Doxycycline’s broad coverage and excellent tissue penetration make it the obvious pick.

Deep abscesses, diabetic foot infections, or proven MRSA? Clindamycin shines despite its CDI risk, especially if you need an oral option after IV therapy.

Always factor in allergy history - a penicillin‑allergic patient may tolerate Cephalexin better than amoxicillin, but cross‑reactivity must be checked.

Talking to Your Doctor

When you’re not sure which antibiotic suits you, bring these points to the consultation:

  1. Describe the infection (location, severity, recent travel).
  2. Mention any known drug allergies.
  3. Ask about pregnancy or breastfeeding considerations.
  4. Inquire about the shortest effective course - many guidelines now favour 5‑day regimens for uncomplicated skin infections.
  5. Request clarification on side‑effects you’re most worried about, like diarrhoea or photosensitivity.

Most GPs will follow NICE guidelines, which currently list Cephalexin as first‑line for uncomplicated cellulitis, but they’ll switch to alternatives if culture results or risk factors dictate.

Frequently Asked Questions

Frequently Asked Questions

Can I take Cephalexin if I’m allergic to penicillin?

Cross‑reactivity is low (about 5%), but you should alert your doctor. If you’ve had a severe reaction, they may opt for a non‑beta‑lactam like doxycycline.

Is Cephalexin safe during pregnancy?

Yes, it’s classified as Category B in the UK, meaning animal studies haven’t shown risk and there’s no evidence of harm in humans. Still, the doctor will weigh benefits against any alternatives.

Why does my doctor sometimes prescribe amoxicillin instead of Cephalexin?

Amoxicillin covers a broader range of Gram‑negative bacteria, making it a better fit for ear, sinus, or mild chest infections. Cephalexin is narrower and cheaper, so it’s chosen when the bug is likely a Gram‑positive skin pathogen.

How long should I stay on Cephalexin?

Typical courses run 7‑10days for skin infections, but recent NICE updates allow 5‑day regimens if symptoms improve quickly. Always finish the prescribed course unless your doctor says otherwise.

What should I do if I develop diarrhoea while on an antibiotic?

Mild diarrhoea is common; stay hydrated and monitor severity. If you see watery stools with abdominal cramping, blood, or fever, contact your GP - it could be C.difficile, especially with clindamycin.

19 Comments

  • Image placeholder

    Erica Dello

    October 1, 2025 AT 15:34

    i notice a lot of inconsistent capitalisation and missing periods in the tables the formatting could be tightened 🙃

  • Image placeholder

    Cherish Capps

    October 3, 2025 AT 18:14

    hey folks i just wanted to say the guide is super helpful dont forget that spelling mistakes happen, but its ok we all learn together :)

  • Image placeholder

    Amy Carpenetti

    October 5, 2025 AT 20:54

    the side‑effect list seems clear and the table layout is easy to read i think it serves both patients and clinicians well

  • Image placeholder

    Paul Griffin

    October 7, 2025 AT 23:34

    Thank you for compiling such a thorough comparison; this will undoubtedly aid many in making informed decisions regarding antibiotic therapy.

  • Image placeholder

    Michael Tekely

    October 10, 2025 AT 02:14

    yo check out the pharmacokinetic jargon – the bioavailability stats and MIC values are solid, just make sure to cross‑reference with local antibiograms for optimal coverage.

  • Image placeholder

    Oscar Taveras

    October 12, 2025 AT 04:54

    Overall the guide strikes a great balance between detail and readability 😊

  • Image placeholder

    katie clark

    October 14, 2025 AT 07:34

    Whilst the exposition is commendably exhaustive, one might argue that the lexical density verges on pedantry, perhaps a modicum of brevity would serve the lay reader.

  • Image placeholder

    Carissa Engle

    October 16, 2025 AT 10:14

    the article attempts a comprehensive side‑by‑side analysis but falls short in several critical dimensions. the first flaw is the superficial treatment of resistance patterns without citing recent surveillance data. a second issue is the lack of discussion about dosage adjustments in renal impairment which is essential for cephalexin. the third shortcoming is the omission of cost‑effectiveness modelling that would inform budgeting decisions. the tone of the piece oscillates between clinical neutrality and a subtle promotional bias towards cephalexin which undermines objectivity. additionally the formatting of the table suffers from inconsistent alignment making comparative reading cumbersome. the reference list is absent entirely leaving the reader without a pathway to verify claims. furthermore the safety profile section glosses over the rare but serious adverse events such as Stevens‑Johnson syndrome which deserve explicit mention. the pregnancy category is noted but the nuances of placental transfer are ignored. the article also fails to address allergic cross‑reactivity in depth despite its clinical relevance. the discussion of alternative agents lacks a clear algorithm for selecting based on infection site. the author could have integrated local guideline recommendations to increase relevance. the plain language used is occasionally marred by medical jargon that may alienate lay audiences. finally the conclusion reiterates the superiority of cephalexin without acknowledging scenarios where alternatives are unequivocally preferred. overall the piece needs deeper evidence, clearer structure, and a more balanced perspective to serve both clinicians and patients effectively

  • Image placeholder

    Lindsey Crowe

    October 18, 2025 AT 12:54

    Sure, because we all love paying more for a pill you don't need.

  • Image placeholder

    Dietra Jones

    October 20, 2025 AT 15:34

    yo the info is good but watch out for the typo's like "cost" sometimes it's mispelled but still helpful lol

  • Image placeholder

    Marcia Hayes

    October 22, 2025 AT 18:14

    Great job on the guide! It really helps people feel confident about their antibiotic choices.

  • Image placeholder

    Danielle de Oliveira Rosa

    October 24, 2025 AT 20:54

    Reading through the comparison, I’m reminded that medical decisions are as much about trust as they are about data; the balanced presentation invites reflective consideration.

  • Image placeholder

    Tarun Rajput

    October 26, 2025 AT 22:34

    Esteemed colleagues, the present compendium of cephalexin and its pharmacopeial peers exemplifies a meticulously curated resource; each pharmacodynamic parameter is articulated with precision, thereby fostering enlightened therapeutic deliberations. The inclusion of cost metrics alongside clinical efficacy underscores an astute appreciation for health‑economic stewardship, a nuance often neglected in cursory reviews. Moreover, the tabular juxtaposition elucidates subtle differentials in spectrum of activity, facilitating nuanced selection predicated upon microbiological acuity. While the discourse laudably navigates safety considerations, an expanded dialogue on pharmacogenomic interactions would augment its contemporary relevance. The narrative’s cadence harmonises scholarly rigor with accessible exposition, rendering it both didactic and pragmatic. I commend the authors for integrating NICE guideline concordance, which anchors the discourse within prevailing practice frameworks. In sum, this guide constitutes a commendable beacon for clinicians navigating the intricate landscape of antimicrobial therapy.

  • Image placeholder

    Joe Evans

    October 29, 2025 AT 01:14

    Hello everyone! 😊, this guide is super useful, it breaks down the antibiotics clearly, and the side‑effect table is spot on, great job! 😊

  • Image placeholder

    Colin Boyd

    October 31, 2025 AT 03:54

    While the comparison is thorough it neglects the emerging role of narrow‑spectrum agents which some argue should be front‑line over broad‑spectrum options

  • Image placeholder

    Rebecca Mikell

    November 2, 2025 AT 06:34

    I appreciate the balanced view and think adding a quick reference chart could further enhance usability for busy clinicians.

  • Image placeholder

    Arjun Santhosh

    November 4, 2025 AT 09:14

    nice guide but maybe put the dosing info in a bullet list so its easier 2 read

  • Image placeholder

    Stephanie Jones

    November 6, 2025 AT 11:54

    One might ponder whether the very act of categorizing antibiotics into hierarchies reflects a deeper human desire to impose order upon the chaotic realm of microbial life.

  • Image placeholder

    Nathan Hamer

    November 8, 2025 AT 14:34

    Wow! This guide is a masterpiece of clarity and compassion! 🌟, it empowers patients and prescribers alike, ushering in a new era of informed antibiotic stewardship! 🙌

Write a comment